Segments - Artificial Kidney Market by Device Type (Implantable Artificial Kidney and Wearable Artificial Kidney), Dialysis (Peritoneal Dialysis, Hemodialysis, and Combination), Application (Pediatrics and Adults), End-user (Ambulatory Surgical Centers, Specialty Clinics, and Hospitals), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The artificial kidney market size was valued at USD 0.11 Bn in 2022 and is expected to reach USD 6.6 Bn by 2031, expanding at a CAGR of 60.35% during 2023–2031. The market growth is driven by the rising number of patients with kidney-related disorders, the limited supply of kidney donors, and increasing research and developments.
An artificial kidney, also known as a bioartificial kidney or renal replacement device, is a medical device designed to replicate the functions of a natural human kidney. The kidneys are essential organs liable for filtering excess fluid and waste products from the blood, maintaining electrolyte balance, and regulating blood pressure.
The demand for artificial kidneys is rapidly growing due to the rising prevalence of chronic kidney disease worldwide. The major cause of chronic kidney disease is diabetes and high blood pressure, which leads to the cause of health problems such as heart disease and strokes. Kidney diseases include glomerulonephritis, IgA Nephropathy, and lupus nephritis can lead to chronic kidney disease, kidney failure, and death.
Artificial kidneys have the potential to improve the quality of life for individuals with kidney failure. Compared to traditional dialysis, which often requires multiple sessions per week and restricts daily activities. The artificial kidney could provide a more continuous and efficient filtration process, allowing patients to have greater freedom and flexibility in their daily lives. The demand for artificial kidneys is increasing as the prevalence of chronic diseases and conditions such as end-stage renal diseases and kidney failures.
The market report finds that the COVID-19 pandemic affected the artificial kidney market. During the virus outbreak, healthcare organizations and research labs primarily focused on developing diagnostic kits, protective equipment, and treatments for the virus. This has led to a lack of attention and resources for other healthcare, including kidney-related treatments. During the pandemic, all the other operations were at a halt due to the lack of medical resources which led to hampering the artificial kidney market.
Rising prevalence of kidney-related disorders around the world drives the artificial kidney market. According to the National Institutes of Health in March 2022, 10% of the global population is living with chronic kidney disease. This means more than 800 million individuals suffer from CKD every year.
CKD is one of the leading causes of mortality across the world owing to complications and high costs related to treatments. Ongoing R&D to develop advanced artificial kidneys is expected to boost market revenue during the forecast period.
Higher costs of advanced devices hamper the market. A new artificial kidney device requires to go through regulatory approval, it often undergoes extensive research, development, and clinical trials, which requires significant costs. Patients and healthcare providers may find it difficult to afford or justify the expense, especially when alternative treatment options such as dialysis are more affordable.
Increasing technological advancements and a growing preference for home-based care create lucrative opportunities for the market. Rapid advancements in medical technology, including nanotechnology, biotechnology, and wearable devices, present opportunities for the development of more efficient and effective artificial kidney systems. Integration of advanced technologies can lead to improved performance of devices and better treatment outcomes.
Increasing development in the production of innovative portable bio-artificial kidneys is also likely to create opportunities for the market. Newer advances are developing in the space of artificial kidneys, often similar and concerning one another. Artificial kidneys that are portable, wearable, or easily implantable can enable patients to receive continuous kidney function at home and helps to improve their quality of life. This is expected to create new pathways for the market in the coming years.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Artificial Kidney Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Device Type (Implantable Artificial Kidney and Wearable Artificial Kidney), Dialysis (Peritoneal Dialysis, Hemodialysis, and Combination), Application (Pediatrics and Adults), and End-user (Ambulatory Surgical Centers, Specialty Clinics, and Hospitals,) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
B. Braun SE; DaVita Inc.; Medtronic; Asahi Kasei Medical Co., Ltd.; Nipro Medical Corporation; Fresenius Medical Care AG & Co. KGaA; Merit Medical Systems; and Baxter. |
Based on device type, the artificial kidney market is divided into implantable artificial kidney and wearable artificial kidney. The wearable artificial kidney segment is anticipated to expand at a major growth rate during the projection period due to rising incidences of end-stage renal and kidney disorders.
Renal disease is a condition in which kidneys stop functioning and are unable to remove excess water and waste from the bloodstream. This disorder causes by high blood pressure, high blood sugar, blocked urinary tract, and chronic glomerulonephritis (kidney damage).
The wearable artificial organs designed for kidneys help to achieve the effective removal of toxins from the blood of patients with kidney failure. Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) are likely to be freed from fixed dialysis machines with wearable artificial kidney devices.
The implantable artificial kidney segment is expected to expand at a significant growth rate in the coming years due to offering improved quality of life and providing long-term solutions. Advancements in medical technology have made implantable artificial devices more advance and effective. This device leads to work more effectively and improves patient outcomes.
The implantable artificial kidney devices offer improved quality of life and reduce the need for external treatments such as dialysis and enhance patient’s mobility. Patients are looking for options that help them to regain their normal abilities and independence. The advantages of implantable artificial devices such as lower long-term healthcare costs and reduced hospital stays.
On the basis of dialysis, the global market is segregated into peritoneal dialysis, hemodialysis, and combination. Hemodialysis is projected to register a considerable CAGR during the forecast period due to the large number of procedures being performed. Hemodialysis is a process where a special filter and a dialysis machine called an artificial kidney, are used to clean blood.
Hemodialysis refers to the specific area focused on hemodialysis treatment, which is a common method of renal replacement therapy. Artificial kidney represents the devices, equipment, and technologies used in hemodialysis treatments. It addresses the needs of individuals with end-stage renal disease or other conditions requiring regular hemodialysis treatments.
The peritoneal dialysis segment is anticipated to hold a significant share of the market, due to convenience with flexibility and continuous treatments. Peritoneal dialysis is a type of renal replacement therapy that uses the peritoneal membrane in the abdomen to filter waste products and excess fluids from the blood. Peritoneal dialysis can be performed at home, which eliminates the need for frequent visits to a dialysis center.
This provides patients with better independence and flexibility in managing their treatment. The ability to perform dialysis at home also reduces travel time and associated costs for patients, making it an attractive option. Peritoneal dialysis offers the advantage of continuous treatment throughout the day, in dissimilarity to hemodialysis, which is usually performed for a few hours, a few times a week.
On the basis of application, the artificial kidney market is segmented into pediatrics and adults. The adults segment is expected to register a robust growth rate during the forecast period due to the increasing prevalence of kidney disease among the adult population. Kidney disease is becoming more common in the adult population with factors including aging and chronic conditions such as diabetes and hypertension. Artificial kidneys offer a promising solution for individuals with end-stage renal disease (ESRD) or severe kidney failure. These devices can help to replace impaired kidney function and improve the quality of life for adult patients.
The pediatric segment is expected to hold a significant share of the market owing to focusing on specialized and customized treatment for pediatric patients. The specific area focused on the treatment of kidney-related conditions in pediatric patients.
Artificial kidney device addresses the unique needs and challenges faced by children with impaired kidney function, such as congenital renal disorders, kidney failure, or other renal diseases. Pediatric patients require specialized care and customized treatment methods due to their different physiological and developmental features.
Based on the end-user, the artificial kidney market is segregated into ambulatory surgical centers, specialty clinics, and hospitals. The hospitals segment is expected to hold a significant market share during the assessment period due to the presence of skilled doctors and advanced healthcare infrastructure. Hospitals are the primary facilities for any surgical operations. A higher number of surgeries and transplantation of organs are performed in hospital settings as these hospitals have advanced facilities for the complete care of the patient before, during, and after the transplantation of the kidney.
The specialty clinics segment is projected to expand at a considerable growth rate during the projection period due to extensive and specialized treatment with expert professionals. Specialty hospitals are available for 24/7 emergency care with facilities such as ambulances, Intensive care units (ICUs), and emergency wards. They have dedicated operation theaters equipped with advanced patient monitoring equipment, anesthesia equipment, and surgical instruments.
Specialty clinics offer specialized expertise and dedicated care for individuals with kidney-related conditions. These clinics focus specifically on kidney diseases, allowing them to provide extensive and specialized treatment options to patients. They may have nephrologists, urologists, dialysis specialists, transplant surgeons, and other healthcare professionals working collaboratively to provide complete care for patients with kidney diseases.
In terms of region, the global artificial kidney market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period due to increasing research and development activities by research centers present in the region.
In North America, there are numerous popular research centers and institutions that are actively involved in studying and developing advanced medical technologies, including artificial kidneys. Research centers invest significant funding and resources into R&D for artificial kidneys. This allows them to carry out research, clinical trial, and innovation in the field of artificial kidneys.
The market in Europe is projected to grow rapidly during the forecast period, due to the presence of well-established healthcare infrastructure. In Europe, healthcare infrastructure includes advanced hospitals and medical centers that specialized in kidney care. These facilities have the necessary expertise and resources to support the development, manufacturing, and use of artificial kidneys.
This healthcare infrastructure ensures that patients with kidney diseases have access to high-quality care and advanced treatment options. It enables the increased availability and widespread adoption of artificial kidneys as a viable and effective treatment option for individuals experiencing impaired kidney function.
The artificial kidney market has been segmented on the basis of
Key players competing in the artificial kidney market are B. Braun SE; DaVita Inc.; Medtronic; Asahi Kasei Medical Co., Ltd.; Nipro Medical Corporation; Fresenius Medical Care AG & Co. KGaA; Merit Medical Systems; and Baxter.
These major players in the artificial kidney market are developing various strategies including mergers, acquisitions, partnerships, collaboration, and new product launches to expand their offerings, technological advancements, production expansion, and consumer base worldwide.
These companies are acknowledged for their substantial contributions to advancement in healthcare and have played a pivotal role in the research and development activities and commercialization of innovative technologies aimed at enhancing patient outcomes. For instance,